Criteria for Access Full review and scientific critique of each application for collection access will be undertaken by the LCTC Post-Trial Tissue Bank Oversight Committee and the appropriate tumour group sub-committee. The following overarching criteria must be met to access samples in this collection:
Prioritisation of access to the collection will be based on scientific merit as judged by the Oversight Committee and sub-committee and cancer research in the relevant speciality. More details on limitation on the use of the collection, along with details on fees, can be found in the access policy. | ||||||
Limitations on use of the Collection Applications are welcome for studies in all areas but, where samples are limited, priority will be given to research directly related to the original purpose of collection i.e. cancer research in the relevant speciality. The collection does not have documented consent by the donor for use of identifiable samples in research. Samples and data will not be released if they do not fall under the scope of the documented consent of donors. Samples will not be transferred outside of the European Economic Area (EAA) or used for genetic studies without explicit consent. Samples cannot be used in research into termination of pregnancy or reproductive cloning. Samples cannot be provided with identifiable information. | ||||||
How to apply The process from initial contact to sample release is described in this flowchart. If you would like to access the collection the first stage is to contact the custodian via e-mail, giving a brief outline of the proposed study, methodology and number and type of samples required. The custodian will assess the suitability of the application and respond to the applicant. Following discussions with the custodian, access to the application form will be provided. | ||||||
Further Information Please click links below for further information: |